Ownership history in Advisory Services Network, LLC · 27 quarters on record
This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in BIOCRYST PHARMACEUTICALS (BCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 7,500 | -28,801 | -79.3% | 0.00% | $57K | $7.59 |
| 2025 Q2 | ADDED | 36,301 | +32,561 | +870.6% | 0.00% | $295K | $8.96 |
| 2023 Q4 | REDUCED | 3,740 | -1,000 | -21.1% | 0.00% | $22K | $5.99 |
| 2023 Q1 | ADDED | 4,740 | +1,500 | +46.3% | 0.00% | $40K | $8.34 |
| 2022 Q4 | REDUCED | 3,240 | -1,610 | -33.2% | 0.00% | $37K | $11.48 |
| 2021 Q2 | REDUCED | 4,850 | -850 | -14.9% | 0.00% | $77K | $15.81 |
| 2020 Q4 | UNCHANGED | 5,700 | — | 0% | 0.00% | $42K | $7.45 |
| 2020 Q3 | UNCHANGED | 5,700 | — | 0% | 0.00% | $20K | $3.44 |
| 2020 Q1 | UNCHANGED | 5,700 | — | 0% | 0.00% | $11K | $2.00 |
| 2019 Q4 | ADDED | 5,700 | +1,700 | +42.5% | 0.00% | $20K | $3.45 |
As of 2025 Q4 — sorted by position size